Zacks Research Has Negative Outlook for ACAD Q1 Earnings
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities research analysts at Zacks Research lowered their Q1 2025 earnings per share (EPS) estimates for shares of ACADIA Pharmaceuticals in a research note issued to investors on Tuesday, March 18th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will post earnings of $0.09 […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities research analysts at Zacks Research lowered their Q1 2025 earnings per share (EPS) estimates for shares of ACADIA Pharmaceuticals in a research note issued to investors on Tuesday, March 18th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will post earnings of $0.09 […]
